Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

Eli Lilly (LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday. The ...

Eli Lilly just scored a major win with its Phase 3 BRAVE-AA-PEDS study. The trial confirmed baricitinib's effectiveness in ...

Eli Lilly (LLY) stock dropped by 0.22%, underperforming the S&P 500’s 0.49% gain. Over the past month, the stock has fallen 4 ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options ... 6. Current RSI values indicate that the stock is may be overbought.

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Impact of US Tariffs and Obesity Drug Performance on the Pharmaceutical Industry Emily Field, Head of […] Eli Lilly and Company ( NYSE:LLY ) just reported healthy earnings but the stock price didn't ...

Shares of Eli Lilly were up by around 0.5% in midday trading Wednesday, at $906.70 a share. The company stock has soared more than 16% since Jan. 1. While many pharmaceuticals are produced ...

Eli Lilly plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the U.S. The drugmaker, which had committed to $23 billion in domestic investments from 2020 ...

Patients and healthcare providers may turn to alternative treatments if Eli Lilly's products are consistently unavailable or in short supply. This could have long-term implications for the company's ...

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...